KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Equity Average (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Equity Average for 12 consecutive years, with $21.9 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 19.3% to $21.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.9 million through Dec 2025, down 19.3% year-over-year, with the annual reading at $26.7 million for FY2025, 14.71% up from the prior year.
  • Equity Average hit $21.9 million in Q4 2025 for ClearPoint Neuro, up from $17.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $47.3 million in Q1 2022 to a low of $17.8 million in Q3 2025.
  • Historically, Equity Average has averaged $32.4 million across 5 years, with a median of $30.3 million in 2023.
  • Biggest five-year swings in Equity Average: skyrocketed 6088.58% in 2021 and later tumbled 41.74% in 2025.
  • Year by year, Equity Average stood at $46.5 million in 2021, then dropped by 17.37% to $38.4 million in 2022, then tumbled by 41.03% to $22.6 million in 2023, then rose by 20.15% to $27.2 million in 2024, then fell by 19.3% to $21.9 million in 2025.
  • Business Quant data shows Equity Average for CLPT at $21.9 million in Q4 2025, $17.8 million in Q3 2025, and $19.9 million in Q2 2025.